Description
PRIME DHB 100 | 1-Testosterone Cypionate (1-TC 100) 100mg/ml
PRIME DHB 100 features 1-Testosterone Cypionate (Dihydroboldenone), a dry, non-aromatizing anabolic steroid known for its powerful lean muscle-building capacity and favorable aesthetic outcomes. It is often selected by advanced users seeking a clean anabolic profile without water retention or estrogenic side effects.
Mechanism of Action:
DHB is a derivative of dihydrotestosterone (DHT) and binds strongly to androgen receptors, promoting muscle fiber growth and density. It does not convert to estrogen, minimizing risks of gynecomastia or fluid retention. Its cypionate ester offers a stable release curve, ensuring consistent serum levels for extended protocols.
Use Case:
Ideal for cutting cycles or recomposition phases where lean mass retention, vascularity, and definition are priorities. DHB is also favored in advanced stacks where synergy with other non-aromatizing agents is desired. Due to its potential for post-injection pain, proper dilution and site rotation are often recommended.
Advantages of High-Concentration Format:
The 100mg/ml concentration supports precise administration while limiting injection volume—a critical factor when incorporating DHB into multi-agent stacks or long-term cycles. PRIME DHB 100 maintains compound integrity while enhancing injection efficiency and control.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.